Page URL:

Scientists create 'living biobank' of cancer samples

11 May 2015
Appeared in BioNews 801

Scientists have announced the creation of miniature tumours that closely mimic real cancers. 

Geneticists at the Wellcome Trust Sanger Institute in Cambridge, UK, used cells from colon cancer tumours to grow 'organoids' - tiny three-dimensional clumps of tumour cells, just 0.1mm in diameter - in the lab. They found that the organoids shared many of the properties of the original tumours and used them to successfully test over 80 cancer drugs, identifying at least one promising new candidate. 

'The beautiful thing here is that we've shown we can grow these organoids in the lab and they look a lot like the tissue from which they were taken, so they should be much better models for studying cancer,' Dr Mathew Garnett, a senior author of the paper that was published in Cell, told the Guardian

Although cancer cells grow rampantly in the body, once they are put into a Petri dish they are hard to keep alive. While cancer cell lines have been grown, these don't tend to behave much like real tumours as they start to develop their own mutations. Tumours can also be grown in immune-deficient mice, but in this case it is hard to conduct large-scale drug tests. 

Dr Garnett and his team used the concept of organoids, which had been developed as models of healthy tissue, to create miniature 3-D tumours. They took cells from biopsies of 20 patients with colorectal cancer to create 22 cancer organoids, and used the patients' healthy tissue to create 19 healthy organoids. They found that the cancer organoids displayed the hallmarks of the original tumours in terms of their 3-D architecture, the cell types present and their genetic profiles

Next they screened the organoids using 83 approved and experimental cancer drugs. It is well known that some genetic mutations will cause a tumour to be resistant to a particular drug, and the organoids displayed the same sensitivity to the cancer drugs as would be expected given their specific mutations. 

One organoid with a mutated RNF43 gene was destroyed by a drug that blocked a protein called porcupine, suggesting that this drug might be useful in patients whose tumour shares that mutation. 

'Cancer is a very diverse disease and we often find that some patients respond to a drug while others don't. The reasons are often poorly understood, but we can use the organoids to try and understand that better,' said Dr Garnett in the Guardian. 'Ultimately this living biobank should enable us to identify populations of patients that we can predict will be most likely to benefit from a specific drug,' he added. 

The researchers now plan to grow organoids for other types of cancer and to use them to test new cancer drugs.

14 October 2019 - by Dr Maria Botcharova 
Structures grown from patient's tumour cells can help identify which patients will benefit from chemotherapy drugs, according to a new study...
18 July 2016 - by Arit Udoh 
A group of international scientists have announced plans to work collaboratively on a research project that aims to develop human cancer models that would better mimic the disease...
24 August 2015 - by Dr Julia Hill 
For the first time, an almost fully formed human brain has been grown in the lab, according to scientists from Ohio State University...
20 July 2015 - by Ayala Ochert 
Scientists have grown miniature brains out of stem cells from people with autism, and have found that they over-produce one type of neuron...
7 April 2014 - by Baroness Delyth Morgan 
The news of Angelina Jolie's mastectomy last year brought breast cancer genetics, risk and prevention into the international spotlight. Her decision was only possible due to the efforts of researchers, over the past twenty years and more, to identify the inherited genetic mutations...
24 March 2014 - by Daryl Ramai 
A stool-sample DNA test has detected 92 percent of colon cancers in a large clinical trial, compared to 74 percent picked up by the most commonly used non-invasive test...
10 February 2014 - by Dr Barbara Kramarz 
Whole genome testing has been used to guide tailored treatment against advanced breast cancer in a group of 43 patients. The scientists behind the study say their research is a step on the path towards 'personalised medicine' where individual genetic makeup informs treatment choice...
22 July 2013 - by Maren Urner 
The world's largest database of cancer-related genetic variations to date has been made available by the National Cancer Institute (NCI), US...
18 August 2008 - by Dr Rachael Panizzo 
Scientists have identified one of the leading genetic causes of inherited colorectal cancer, reported in the journal Science. Research teams at the Northwestern University Feinberg School of Medicine and the Human Cancer Genetics Program at Ohio State University found that abnormal activity of the transforming growth factor-beta...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.